Latest News for: bio

Edit

Wildlife bio to show photos

Billings Gazette 15 Feb 2026
Born and raised on the north edge of the Greater Yellowstone Ecosystem in Livingston, Shawn Stewart has been fortunate enough to be working as a wildlife biologist for Montana Fish, Wildlife & Parks in the region for more than 50 ... .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Palisade Bio Inc)

Public Technologies 14 Feb 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... 0.5 ... 2 ... PALISADE BIO, INC ... 3 ... Palisade Bio Inc.
Edit

Sierra Leone’s President Julius Maada Bio Calls For Renewed Unity And Action On UN Security Council Reform (Government of the Republic of Sierra Leone)

Public Technologies 14 Feb 2026
President Bio reaffirmed Africa's unwavering position, stressing that the continent seeks not less than two permanent seats with full prerogatives, including the veto, and five non-permanent seats.
Edit

San Mateo County Youth Commission hosts program to promote ‘bio-empathy’

The Daily Journal - San Mateo 13 Feb 2026
A program getting middle and high schoolers outdoors in San Mateo County is looking to do far more than get kids’ hands dirty, it is working to develop deep connections between the youth and the natural world to better combat ... .
Edit

INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB (Form 8-K) (INmune Bio Inc)

Public Technologies 13 Feb 2026
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB ... 10, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc ... While advancing the regulatory pathway in the UK, INmune Bio also stands to benefit from recent U.S ... About INmune Bio Inc.
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

PR Newswire 13 Feb 2026
NEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. ("Instil" or the "Company") (NASDAQ ... On January 6, 2026, Instil issued a press release announcing that Axion Bio, Inc ... . ... 7980 ... 21% ... .
Edit

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

Business Wire 13 Feb 2026
BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today ...
Edit

CTK Bio Develops Breakthrough Sustainable Superabsorbent Technology

Canada Newswire 13 Feb 2026
13, 2026 /CNW/ - CTK Bio has developed a breakthrough sustainable superabsorbent technology that delivers improved performance while addressing key environmental challenges in the personal hygiene market ... CTK Bio - Hydrogel (CNW Group/CTK Bio).
Edit

Notice of Sales of Unregistered Securities (Form D) (Kala Bio Inc)

Public Technologies 13 Feb 2026
). The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete ... Washington, D.C. 20549. FORM D ... OMB Number ... KALA BIO, Inc ... KALA BIO, Inc ... KALA BIO, Inc ... Kala Bio Inc.
Edit

Designation of Securities Under Supervision (Confirmation): TAKARA BIO INC. (Japan Exchange Group Inc)

Public Technologies 13 Feb 2026
) Feb. 13, 2026 TSE Designation of Securities Under Supervision (Confirmation). TAKARA BIO INC. Post. TSE has designated an issue as a Security Under Supervision (Confirmation) as follows. 1.Issue Name TAKARA BIO INC ... 3.Details of Reason TAKARA BIO INC.
Edit

Financial Results Reference (Takara Bio Inc)

Public Technologies 13 Feb 2026
). Financial Re3ulW3内or Whe Third QuarWer Ended December 31, 2025. February 13, 2026. Note ... CReference). Reference Information ... Net Sales by Category (3Q) ... 1 ... Takara Bio ... Takara Bio Europe (Consolidated) ... Takara Bio USA ... bio-ir@takara-bio.co.jp ... Takara Bio Inc.
Edit

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi (STADA Arzneimittel AG)

Public Technologies 13 Feb 2026
) STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi. European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA.
×